Evidence map›Paper›PMID 37287470›Full record

ArticleAlzheimer's & dementia (New York, N. Y.)

Barriers and facilitators to participating in Alzheimer's disease biomarker research in black and white older adults.

Johanne Eliacin, Angelina J Polsinelli, Francine Epperson, Sujuan Gao, Sarah Van Heiden, Glenda Westmoreland, Ralph Richards, Mollie Richards, Christopher Campbell, Hugh Hendrie and 3 more

Open access · goldAbstract read
In one paragraph

Article in Alzheimer's & dementia (New York, N. Y.). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
5.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it, 20 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Johanne EliacinDepartment of Internal General Medicine Indiana University School of Medicine Indianapolis Indiana USA.
Angelina J PolsinelliIndiana Alzheimer's Disease Research Center Indianapolis Indiana USA.ORCID https://orcid.org/0000-0002-7738-9574
Francine EppersonIndiana Alzheimer's Disease Research Center Indianapolis Indiana USA.
Sujuan GaoIndiana Alzheimer's Disease Research Center Indianapolis Indiana USA.
Sarah Van HeidenIndiana Alzheimer's Disease Research Center Indianapolis Indiana USA.
Glenda WestmorelandDepartment of Medicine Indiana University School of Medicine Indianapolis Indiana USA.
Ralph RichardsIndiana Alzheimer's Disease Research Center Indianapolis Indiana USA.
Mollie RichardsIndiana Alzheimer's Disease Research Center Indianapolis Indiana USA.
Christopher CampbellIndiana Alzheimer's Disease Research Center Indianapolis Indiana USA.
Hugh HendrieIndiana Alzheimer's Disease Research Center Indianapolis Indiana USA.
Shannon L RisacherIndiana Alzheimer's Disease Research Center Indianapolis Indiana USA.
Andrew J SaykinIndiana Alzheimer's Disease Research Center Indianapolis Indiana USA.
Sophia WangIndiana Alzheimer's Disease Research Center Indianapolis Indiana USA.
Indiana University School of MedicineIndiana University Bloomington · USRegenstrief Institute · US

Funding

Research Education ComponentP30AG010133 · NIA · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI SAYKIN, ANDREW J · 1991 to 2020
$37.3M
Research Education ComponentP30AG072976 · NIA · INDIANA UNIVERSITY INDIANAPOLIS · PI ANDREW J SAYKIN · 2021 to 2026
$24.1M
Memory Circuitry in MCI and Early Alzheimer’s Disease Prodrome: Molecular DriversR01AG019771 · NIA · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI SAYKIN, ANDREW J · 2001 to 2021
$6.9M
Cognitive Aging, Alzheimers disease, and Cancer-related Cognitive DeclineR01AG068193 · NIA · GEORGETOWN UNIVERSITY · PI MANDELBLATT, JEANNE, SAYKIN, ANDREW J · 2020 to 2023
$2.8M
NIA NIH HHS P30 AG010133NIA NIH HHS P30 AG072976NIA NIH HHS R01 AG019771NIA NIH HHS R01 AG068193
6 · The paper itself

Abstract

Introduction: The study examined Black and White prospective participants' views of barriers to and facilitators of participation in Alzheimer's disease (AD) biomarker research. Methods: In a mixed-methods study, 399 community-dwelling Black and White older adults (age ≥55) who had never participated in AD research completed a survey about their perceptions of AD biomarker research. Individuals from lower socioeconomic and education backgrounds and Black men were over-sampled to address perspectives of traditionally under-represented groups. A subset of participants ( Results: Most participants expressed interest in biomarker research (overall 69%). However, Black participants were comparatively more hesitant than White participants (28.9% vs 15.1%), were more concerned about study risks (28.9% vs 15.1%), and perceived multiple barriers to participating in brain scans. These results persisted even after adjusting for trust and perceived knowledge of AD. Information was a primary barrier (when absent) and incentive (when provided) for AD biomarker research participation. Black older adults desired more information about AD (eg, risk, prevention), general research processes, and specific biomarker procedures. They also desired return of results to make informed decisions about their health, research-sponsored community awareness events, and for researchers to mitigate the burden placed on participants in research (eg, transportation, basic needs). Conclusion: Our findings increase representativeness in the literature by focusing on individuals with no history of AD research experience and those from traditionally underrepresented groups in research. Results suggest that the research community needs to improve information sharing and raising awareness, increase their presence in the communities of underrepresented groups, reduce incidental costs, and provide valuable personal health information to participants to increase interest. Specific recommendations for improving recruitment are addressed. Future studies will assess the implementation of evidence-based, socioculturally sensitive recruitment strategies to increase enrollment of Black older adults into AD biomarker studies.

Indexed as

Alzheimer's diseasebiomarker research proceduresBlack adultscommunity engaged researchhealth disparitiesminority healthneuroimagingresearch participation

Identifiers

PMID37287470
PMCPMC10242196
OpenAlexW4379740057

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.